Page 1 of Clinical Trials for Drug Basiliximab, 94 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Last Updated: August 17, 2010
Condition(s): Non-infectious Uveitis
2
Completed
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
Last Updated: August 9, 2011
Condition(s): Kidney Transplantation
3
Not yet recruiting
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Last Updated: December 2, 2011
Condition(s): Graft Versus Host Disease; Steroid Refractory GVHD; Acute GVH Disease
4
Not yet recruiting
Pharmacodynamics, Efficacy, Safety of Basiliximab 40 or 80 mg Combined With CsA or Everolimus, in Low Risk de Novo Renal Transplant Recipients
Last Updated: March 1, 2012
Condition(s): Renal Transplantation
5
Recruiting
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Last Updated: May 8, 2012
Condition(s): Renal Transplantation
6
No longer available
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Last Updated: March 7, 2012
Condition(s): Type 1 Diabetes Mellitus
7
Active, not recruiting
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Last Updated: May 15, 2012
Condition(s): Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Non-Hodgkin's Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis; Anemia, Aplastic; Hemoglobinuria, Paroxysmal
8
Completed
Basiliximab in Moderate to Severe Ulcerative Colitis
Last Updated: December 17, 2008
Condition(s): Ulcerative Colitis
9
Completed
Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
Last Updated: February 26, 2009
Condition(s): Kidney Transplantation
10
Terminated
Basiliximab Maintenance in Ulcerative Colitis
Last Updated: February 2, 2010
Condition(s): Ulcerative Colitis
11
Recruiting
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
Last Updated: May 24, 2011
Condition(s): Reduction in Sequelae Related to Calcineurin Inhibitors; Chimeric Antibody Sensitization; Allograft Rejection
12
Completed
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Last Updated: August 10, 2011
Condition(s): Kidney Transplantation
13
Completed
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids
Last Updated: August 17, 2011
Condition(s): Liver Transplantation; Infection
14
Not yet recruiting
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
Last Updated: November 18, 2011
Condition(s): Recurrent Adult Hodgkin Lymphoma
15
Terminated
In-Vivo Activated T-Cell Depletion to Prevent GVHD
Last Updated: March 29, 2012
Condition(s): Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Lymphoma, Non-Hodgkin's; Mantle-Cell Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis
16
Active, not recruiting
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
Last Updated: September 8, 2011
Condition(s): Brain and Central Nervous System Tumors
17
Recruiting
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance
Last Updated: June 9, 2011
Condition(s): Kidney Transplant
18
Recruiting
Optimization of NULOJIX® (Belatacept) Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Last Updated: November 4, 2011
Condition(s): Kidney Transplantation
19
Recruiting
LEA29Y (Belatacept) Emory Edmonton Protocol
Last Updated: October 5, 2011
Condition(s): Type 1 Diabetes Mellitus
20
Completed
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids
Last Updated: January 28, 2011
Condition(s): Denovo Renal Transplantation

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Basiliximab

Page 1 of Clinical Trials for Drug Basiliximab, 94 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About